GDF6 Alleviates Pathological Cardiac Hypertrophy via AMPKα Signaling Pathway. [PDF]
Ren Q, Wang Z, Ren W.
europepmc +1 more source
Astragaloside IV prevents calpain-1-mediated cardiac hypertrophy and fibrosis induced by diabetes. [PDF]
Zhang Q, Zhao N, Wei S, Lu M, Chen K.
europepmc +1 more source
Tectochrysin alleviates Ang II-induced pathological cardiac hypertrophy by binding to STING and inhibiting STING/NFκB-mediated inflammation. [PDF]
Chen Y, Li F, He Y, Ling Z.
europepmc +1 more source
Fructose and salt induce sex- and ovary dependent cardiac hypertrophy in Dahl salt-sensitive rats. [PDF]
Akhtar MA +6 more
europepmc +1 more source
Transient elevation in cellular glucose uptake exacerbates pressure overload-induced cardiac hypertrophy and dysfunction. [PDF]
Bakshi S +9 more
europepmc +1 more source
High-Throughput Cardiac Hypertrophy Phenotyping Supports Lead Optimization of GRK5 Inhibitors. [PDF]
Steinkuhl P +8 more
europepmc +1 more source
Platycodin D alleviates cardiac hypertrophy in the treatment of heart failure by inhibiting p53-dependent BCL-2/Bax/caspase-3 signaling pathway. [PDF]
Li Y, Li H, Liu B, Li Y.
europepmc +1 more source
Regulation of cardiac hypertrophy by RNA readers. [PDF]
Costantino S, Paneni F.
europepmc +1 more source
SNX16 aggravates AngII-induced cardiac hypertrophy in mice via EGFR transactivation. [PDF]
Xie L +17 more
europepmc +1 more source

